Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiontech Se Adr Share News (0A3M)

Share Price Information for Biontech Se Adr (0A3M)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 91.375
Bid: 89.10
Ask: 93.65
Change: 3.70 (4.22%)
Spread: 4.55 (5.107%)
Open: 90.60
High: 91.825
Low: 88.35
Prev. Close: 87.675
0A3M Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WHO claims new loans and bonds could fill $28bn gap for coronavirus funding

Tue, 15th Dec 2020 12:55

(Sharecast News) - The World Health Organization claims that new loans and bonds could help fill a $28bn funding shortfall for combating the coronavirus pandemic, an official said on Tuesday.
According to Reuters, Bruce Aylward, a senior official at the WHO, said the new financing mechanisms including concessional loans and catastrophe bonds could be used to fill the gap in funding.

The Covid-10 funding facility called Access to Covid-19 Tools (ACT) Accelerator, would be used to provide poor and middle-income countries with diagnostic tests, drugs and vaccines. It was set up last April.

"Right now financing is what stands between us and getting out of this pandemic as rapidly as possible," Aylward told a UN briefing in Geneva on Tuesday.

"It's a real challenge in today's fiscal environment despite the fact that this is the best deal in town," Aylward said, referring to the ACT Accelerator facility. "This will pay itself off in 36 hours once we get trade and travel moving again."

He also said that the organization was in talks with drugmaker Pfizer to include its vaccine as part of an early global roll out.

There seemed to be a "strong commitment" on the part of Pfizer CEO Albert Bourla to set low prices to help poorer countries be able to acquire the shots, he reportedly added.
More News
4 Jun 2021 16:44

UK approves Pfizer-BioNTech Covid-19 vaccine shot for use in 12-15 year olds

(Sharecast News) - Britain has approved the Covid-19 vaccine jointly developed by Pfizer-BioNTech for use in children ages 12 to 15.

Read more
17 Feb 2021 10:19

Pfizer-BioNTech to supply EU with additional 200m doses of Covid-19 vaccine

(Sharecast News) - Pfizer and BioNTech have agreed to supply the European Union with an additional 200 million doses of their Covid-19 vaccine.

Read more
10 Feb 2021 15:30

BioNTech starts Covid-19 vaccine production at new Marburg plant

(Sharecast News) - BioNTech has started production of its Covid-19 vaccine from a new manufacturing site in Marburg, Germany.

Read more
5 Jan 2021 12:51

EU negotiating boost in Covid-19 doses from Pfizer/BioNTech to 600m

(Sharecast News) - Brussels is negotiating a deal with Pfizer and BioNTech to provide enough Covid-19 vaccine doses to inoculate as much as two-thirds of the bloc's population.

Read more
30 Dec 2020 11:51

China's Sinopharm seeks Covid vaccine approval at 79% effectiveness

(Sharecast News) - Chinese Covid-19 vaccine developer Sinopharm said it will seek approval from regulators after final stage trials showed a 79% efficacy rate.

Read more
9 Dec 2020 12:57

People with severe allergies told to avoid Pfizer-BioNTech Covid vaccine

(Sharecast News) - People who have severe allergies should not receive the Pfizer-BioNTech Covid-19 vaccine, the UK regulator has announced.

Read more
11 Nov 2020 12:48

EU agrees deal for up to 300m doses of Pfizer's potential Covid-19 vaccine

(Sharecast News) - The European Union has finalised a deal with US drugs giant Pfizer to acquire up to 300m doses of its experimental Covid-19 vaccine, with delivery potentially starting as soon as December.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.